DOLIPRANE

1 G · comprimé sécable · box of 10

paracétamol

Reference dated : 2026-06-02. Confirm price and availability with a pharmacist.

Public price

13,10 MAD

Laboratory

BOTTU S.A.

Composition and presentation

DOLIPRANE 1 G — paracétamol. Listed presentation: 1 G · Comprimé sécable · Boîte de 10.

Full clinical reference

Additional sections are available in French. Read the original document; the information concerns the French reference product.

Uses

Symptomatic treatment of mild to moderate pain and/or fever.

Adults and children from 50 kg (approximately 15 years).

Pregnancy and breastfeeding

Pregnancy

A vast amount of data concerning pregnant women demonstrates the absence of any malformation or any fetal/neonatal toxicity. Epidemiological studies dedicated to the neurodevelopment of children exposed to paracetamol in utero produce inconclusive results. If this proves necessary from a clinical point of view, paracetamol can be used during pregnancy; however, it should be used at the lowest effective dose, for the shortest possible duration and at the lowest possible frequency.

Breastfeeding

After administration, paracetamol is eliminated in small amounts in breast milk. At therapeutic doses, the administration of this medicine is possible during breastfeeding.

Fertility

Due to the potential mechanism of action on cyclo-oxygenases and prostaglandin synthesis, paracetamol could alter fertility in women, through an effect on ovulation reversible upon discontinuation of treatment.

Effects on male fertility have been observed in an animal study. The relevance of these effects in humans is unknown.

Driving

Paracetamol has no effect or only a negligible effect on the ability to drive vehicles and use machines.

Adverse effects

Adverse effects are classified by system-organ class. Their frequencies are defined as follows:

· Very common ( ≥ 1/10)

· Common ( ≥ 1/100 to < 1/10)

· Uncommon ( ≥ 1/1 000 to < 1/100)

· Rare ( ≥ 1/10 000 to < 1/1 000)

· Very rare (< 1/10 000)

· Frequency unknown (cannot be estimated based on available data)

System organ class	Rare ( ≥ 1/10 000 to < 1/1 000)	Very rare (< 1/10 000)	Frequency unknown
Hematological and lymphatic system disorders		Thrombocytopenia, Leucopenia, Neutropenia
Immune system disorders	Hypersensitivity reactions 1		Anaphylactic reaction (including hypotension) 1, Anaphylactic shock 1, Angioedema (Quincke's edema) 1
Respiratory, thoracic and mediastinal disorders			Bronchospasm (cases of bronchospasm have been identified with paracetamol, mostly in asthmatic patients sensitive to aspirin or other non-steroidal anti-inflammatory drugs).
Metabolism and nutrition disorders			Metabolic acidosis with high anion gap 3
Gastrointestinal disorders	Diarrhoea, Abdominal pain.
Hepatobiliary disorders			Increase in liver enzymes
Skin and subcutaneous tissue disorders	Erythema 1, Urticaria 1, Skin rash 1, Purpura 2	Serious skin reactions 1	Fixed pigment erythema
1 Their occurrence requires immediate and permanent discontinuation of this medicinal product and related medicinal products. 2 The occurrence of this effect requires immediate discontinuation of this medicinal product. The medicinal product may be reintroduced only on medical advice. 3 Cases of metabolic acidosis with high anion gap due to pyroglutamic acidosis have been observed in patients presenting risk factors and taking paracetamol (see section 4.4). A pyroglutamic acidosis may occur in these patients due to low glutathione levels

Reporting of suspected adverse effects

Reporting suspected adverse effects after the medicinal product has been authorised is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals report any suspected adverse effect via the national reporting system: French National Agency for Medicines and Health Products Safety (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr/ .

Read the French reference

Hospital price

8,20 MAD

ATC code

N02BE01

Type

Originator

References and update dates

Historical reference; confirm the price with a pharmacist.

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-02: 13,10 MAD

Same ingredient, strength and form

This grouping does not establish interchangeability.

ANDOL

1000 MG · comprimé sécable · box of 8

9,90 MAD

CETAMYL

1 G · comprimé sécable · box of 10

12,30 MAD

Other strengths and forms

Routes and instructions may differ.